Tag: DC Healthcare

DC Healthcare Holdings Berhad (DC Healthcare or the Group), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, is pleased to announce the opening of one Dr. Chong Clinic and one DC Body in KL Publika Shopping Gallery as well as one DC Body Johor Bahru Bukit Indah following the successful launch of multiple Dr. Chong Clinics and DC Body outlets across Malaysia. These additions aim to enhance the availability of DC Healthcare’s top-quality wellness and aesthetic services.

Dr Chong Clinic – KL Publika Shopping Gallery continues the Group’s offering of premier aesthetic services, building on the reputation of excellence that DC Healthcare has established. Meanwhile, DC Body – KL Publika Shopping Gallery and Johor Bahru Bukit Indah represent an innovative leap for DC Healthcare, extending the Group’s offerings into specialised weight management, personalised nutrition counselling and body contouring.

Dr. Chong Tze Sheng, Managing Director of DC Healthcare said, “The positive feedback from our customers from the recent outlets openings of Dr Chong Clinic and DC Body in Ipoh, Johor, Penang and Selangor has inspired us to continue growing. Our new facilities at Publika and Bukit Indah reinforce our commitment to meet the demand for professional wellness and beauty services. We look forward to serving more customers in these new locations.”

He added, “The selection of Publika aligns with the Group’s strategy to integrate into areas that support the lifestyle preferences of our clients. Both new establishments are designed to meet the high standards of care and professionalism expected from DC Healthcare.”

In 2024, DC Healthcare has expanded its reach by opening four Dr. Chong Clinics located in Taman Molek (Johor Bahru), Bandar Seri Botani (Ipoh), Auto City (Pulau Pinang), and Publika (Kuala Lumpur), as well as four DC Body outlets in USJ Taipan (Selangor), Auto City (Pulau Pinang), Publika (Kuala Lumpur), and Bukit Indah (Johor Bahru). With these latest additions, DC Healthcare now operates a total of 17 medical aesthetic clinics and 4 DC Body outlets nationwide, significantly enhancing the accessibility and availability of its premium wellness and aesthetic services to a broader audience.

Group Continues to Expand in Major Cities

DC Healthcare Holdings Berhad (DC Healthcare or the Group), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, is pleased to announce the opening of two new outlets: Dr Chong Clinic and DC Body, both located in Perai Pulau Pinang (Auto City). These new establishments underscore the Group’s commitment to expanding its reach and enhancing the accessibility of the Group’s top-tier aesthetic and wellness services.

Dr Chong Clinic – Perai Pulau Pinang (Auto City) continues the Group’s offering of premier aesthetic services, building on the reputation of excellence that DC Healthcare has established. Meanwhile, DC Body – Perai Pulau Pinang (Auto City) represents a new frontier for the Group, focusing on beauty, wellness, and weight management. Developed in collaboration with medical professionals from Dr. Chong Clinic and certified nutritionists, DC Body is set to revolutionise the approach to wellness with the Group’s comprehensive, personalised treatment plans and state-of-the-art technology.

Dr. Chong Tze Sheng, Managing Director of DC Healthcare, shared his excitement about the new outlets, stating, “The opening of Dr Chong Clinic and DC Body in Perai, Pulau Pinang is a landmark moment for us, broadening our horizons in the realms of health and beauty. These outlets embody our commitment to delivering a wide spectrum of services that cater to the diverse needs of our clients. With a unique blend of aesthetic expertise and wellness solutions, we’re set to offer Perai transformative experiences rooted in excellence and innovation. This expansion is more than just growth; it’s a testament to our vision of integrating beauty with well-being, ensuring our clients receive the best care possible.”

He added, “I’m immensely proud of our team for making this vision a reality and eagerly anticipate the positive impact we’ll bring to the Perai community.” The introduction of these new outlets comes at a time when the demand for aesthetic and wellness services is experiencing robust growth. With an emphasis on creating a serene and rejuvenating environment.”

DC Body is poised to become a sanctuary for those seeking to embark on a journey towards a healthier, more vibrant self. The center’s focus on weight management nutrition, body contouring and  delivered by a team of dedicated specialists in ensuring a holistic approach to wellness.

As DC Healthcare continues to expand the Group’s geographical footprint, the strategic locations of these new outlets in Perai are expected to play a pivotal role in the Group’s growth trajectory. With an unwavering commitment to innovation and quality, DC Healthcare is well-positioned to lead the charge in the evolving landscape of aesthetic medicine and wellness, promising a brighter, healthier future for its clients.

DC Healthcare Holdings Berhad (DC Healthcare or the Group), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, is pleased to announce the openings of the Group’s new branches in Johor Bahru (Taman Molek), and Ipoh (Bandar Seri Botani). These new facilities underscore DC Healthcare’s ongoing commitment to extending reach and making premier aesthetic treatments more accessible across Malaysia.

Equipped with advanced aesthetic technologies and staffed by a team of seasoned professionals, the new branches reflect DC Healthcare’s dedication to excellence and patient-centered care. The introduction of these facilities aligns with the Group’s strategic vision to enhance its service portfolio and fortify the presence within the aesthetic medicine industry.

Dr. Chong Tze Sheng, Managing Director of DC Healthcare, shared his insights on the expansion, “The inauguration of our new branches in Johor Bahru and Ipoh, are key milestones in our journey of growth. These developments not only enhance our service capabilities but also bring us closer to our clients, offering them unparalleled access to top-tier aesthetic solutions. We are excited about the future and remain committed to leading the way in aesthetic medicine in Malaysia and beyond.”

As DC Healthcare continues to navigate the evolving landscape of aesthetic medicine, its strategic initiatives with the branch expansions, position the Group well for sustained success and leadership in the industry.

Advanced Skincare Solutions Designed by Aesthetic Experts Set to Transform the Industry Landscape; Further Diversifying DC Healthcare’s Portfolio

DC Healthcare Holdings Berhad (DC Healthcare or the Company), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, announced today the launch of ‘newB,’ a state-of-the-art skincare line developed by its subsidiary, Ten Doctors Sdn Bhd (10DRS). The new range is segmented into two categories: newB Premium Ageless and newB Premium Hydration, both formulated to set new standards in skincare efficacy.

Engineered with the revolutionary ingredient DiamondC60™, the newB Premium Ageless range delivers potent anti-ageing benefits. This ground-breaking ingredient contains Japan Quality Fullerene “The First Natural Fullerene in Malaysia directly from Japan”, exhibits superior anti-oxidative performance compared to traditional anti-ageing components like Vitamin C.

In parallel, the newB Premium Hydration collection is empowered by the innovative 7HA Boost Complex. This advanced formulation incorporates seven distinct molecular sizes of hyaluronic acid and FUCOGEL®, ensuring ultimate water-boost for lasting healthy, soft and plump skin.

Dr. Chong Tze Sheng, Managing Director of DC Healthcare, stated, “The launch of newB is a strategic move in diversifying our healthcare portfolio. Our skincare products are developed with scientific precision, catering to the evolving skincare needs of our clientele. These new product lines not only contribute to our revenue streams but also enhance our reputation as a comprehensive healthcare provider. We are particularly encouraged by the commercial applications of DiamondC60™, an ingredient that we believe will set new industry standards.”

Amid projections for the Malaysian aesthetic medicine market to register a CAGR of 18.8% from 2021 to 2027, the introduction of newB resonates with DC Healthcare’s commitment to innovation and excellence. The new skincare ranges are available for purchase through multiple online platforms, including Shopee, Lazada, TikTok shop, and Watsons Malaysia Online Store.

Moving forward, DC Healthcare will continue to focus on its core business, which includes aesthetic services and innovative healthcare solutions like newB. The Company plans to expand existing clinics, invest in cutting-edge technology, and fortify its team of medical professionals to capitalise on the growth opportunities presented by the aesthetic medicine market.

As at 31 October 2023, the share price of DC Healthcare stands at 0.52 sen per share, reflecting a market capitalisation of RM518.1 million.

For more information, please visit this LINK.

• Group to focus on expanding network of clinics across northern and southern regions of Peninsular Malaysia

DC Healthcare Holdings Berhad, an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, today debuted on the ACE Market of Bursa Malaysia Securities Berhad, opening at RM0.40 per share representing a premium of 60% over the initial public offering (IPO) price of RM0.25 per share.

DC Healthcare is listed under the stock name of “DCHCARE” and stock code of “0283”.

DC Healthcare currently operates 13 aesthetic clinics in the central and southern regions of Peninsular Malaysia. The Group provides aesthetic medical services such as facial sculpting and body contouring and, general medical services focusing on skin diseases such as psoriasis and eczema, as well as blood test health screening.

The Group raised a total of RM49.81 million through the IPO, from which RM9.44 million is allocated for the establishment of 8 new clinics across the northern and southern regions of Peninsular Malaysia. Another RM13.12 million of the proceeds will be used to purchase medical machinery and equipment while RM6.24 million of the proceeds is allocated for repayment of borrowings. Another RM17.01 million of the proceed is allocated for working capital purposes The remaining RM4.0 million has been allocated for listing expenses.

Chairman of DC Healthcare, Datuk Dr. Mohd Noor Bin Awang said, “The listing of DC Healthcare, an established aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, will allow us to benchmark ourselves as the first aesthetic medical services provider to be listed on Bursa Securities.”

Managing Director of DC Healthcare, Dr. Chong Tze Sheng said, “This is a significant milestone for the Group and evidence of how far we have come as a business to be a leading provider of aesthetic services in Malaysia. Through this listing, we not only cement our success, but we can also continue to build on what we have to bring more value to shareholders”.

Managing Director of Corporate Finance, M&A Securities Sdn Bhd, Datuk Bill Tan said, “We would like to commend the hard work and dedication of Dr. Chong and the DC Healthcare team. The prospects for DC Healthcare are on a positive uptrend based on the rapid growth, demand and success of aesthetic services in Malaysia.”

According to the independent market report attached to DC Healthcare’s prospectus, the Malaysian aesthetic medicine market was valued at RM468.8 million in 2022, up from RM366.3 million in 2021. It is projected to register a CAGR of 18.8% from 2021 to 2027 to RM1.03 billion.

The report noted that demand for aesthetic medical services stems from higher disposable income for Malaysians due to continued economic recovery, and a growing ageing population. These services are further supported by social media culture that has largely removed the stigma associated with aesthetic medical procedures.

M&A Securities Sdn Bhd, is the Principal Adviser, Sponsor, Underwriter and Placement Agent for the IPO exercise.

DC Healthcare Holdings Berhad: http://dchealthcareholdings.com/

Image
Ms. Sim Lee San, Independent Non-Executive Director, DC Healthcare Holdings Berhad
Datuk Dr. Mohd Noor Bin Awang, Independent Non-Executive Chairman, DC Healthcare Holdings Berhad
Dr. Chong Tze Sheng, Managing Director, DC Healthcare Holdings Berhad
Dr. Lai Ngan Chee, Executive Director, DC Healthcare Holdings Berhad
Ms. Rekha A/P Palanysamy, Independent Non-Executive Director, DC Healthcare Holdings Berhad
Ms. Yap Ee Ling, Independent Non-Executive Director, DC Healthcare Holdings Berhad [L-R]
( https://photos.acnnewswire.com/tr:n-650/20230717.DCHealthcare.jpg )

• Group plans to open clinics in northern region of Peninsular Malaysia while expanding presence in southern region

DC Healthcare Holdings Berhad, an established aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, launched the prospectus today in conjunction with the Group’s initial public offering (IPO) on the ACE Market of Bursa Malaysia Securities Berhad.

The IPO will raise RM49.81 million via the issuance of 199.26 million new shares at the IPO price of RM0.25 per share to fund DC Healthcare’s growth plans as well as working capital and repayment of borrowings. The proceeds will be used in the following manner:

– RM9.44 million to establish aesthetic medical clinics
– RM13.12 million to purchase medical machinery and equipment
– RM6.24 million to repay borrowings
– RM17.01 million for working capital, including staff salaries as well as medical supplies and consumables
– RM4.00 million for estimated listing expenses

Managing Director of DC Healthcare, Dr. Chong Tze Sheng said, “DC Healthcare’s expansion plan is based on demand for aesthetic medical services as people are becoming more aware on skin health, as well as wanting to look and feel good about themselves, especially in the long run. It is projected that aesthetic medical services and general medical services related to skin disease will increase due to people having more disposable income for discretionary spending and becoming better educated on skin conditions.”

Mr. Danny Wong, Deputy Head of Corporate Finance, of M&A Securities Sdn Bhd said, “The Malaysian market for aesthetic medical services will continue to grow supported by demand as incomes rise and populations aged. This will be helped along by the increased consumerism and growing influence of social media removing the stigma of aesthetic medical procedures. With the growing acceptance of such treatments, the domestic aesthetic medical services market is projected to have a compound annual growth rate of 18.8% from 2021 to 2027 valuing the total market at RM1.03 billion.”

DC Healthcare – or famously known ‘Dr. Chong Clinic’ or ‘Klinik Dr. Chong’ – provides aesthetic services, general medical services and sale of skincare products. DC Healthcare currently has 13 clinics and 10 LCP Certified Aesthetic Physicians, assisted by 29 resident medical doctors in the central and southern regions of Peninsular Malaysia namely in Negeri Sembilan, Selangor, Johor, and Kuala Lumpur.

For the financial year ended 31 December 2022 (FYE2022), the Group recorded revenue of RM51.96 million compared with RM25.48 million in FYE2021 with a net profit margin of 18.40% and 18.06% respectively.

Aesthetic services contributed 89.96% to total revenue for FYE2022 and 84.88% in FYE2021, compared to general medical services who contributed 10.04% in FYE2022 and 15.12% in FYE2021.

In addition, for the financial year ended 31 December 2020 (FYE2020) and 31 December 2019 (FYE2019), DC Healthcare registered revenue RM14.45 million and RM12.21 million respectively. Aesthetic services contributed 89.80% in FYE2019 and 87.50% in FYE2020 to the total revenue, while general medical services contributed 10.20% in FYE2019 and 12.50% in FYE2020.

DC Healthcare Holdings Berhad: http://dchealthcareholdings.com/

Image 1
DR. CHONG TZE SHENG, Managing Director; DATUK BILL TAN, Managing Director of Corporate Finance, M&A Securities Sdn Bhd [L-R]
( https://photos.acnnewswire.com/tr:n-650/2023627.DCHealthcare1.jpg )

Image 2
1. Mr. Lee Yoke Wah, Associate Director of Corporate Finance, M&A Securities Sdn Bhd
2. Ms. Sim Lee San, Independent Non-Executive Director, DC Healthcare Holdings Berhad
3. Ms. Rekha A/P Palanysamy, Independent Non-Executive Director, DC Healthcare Holdings Berhad
4. Datuk Dr Mohd Noor Bin Awang, Independent Non-Executive Chairman, DC Healthcare Holdings Berhad
5. Dr. Chong Tze Sheng, Managing Director, DC Healthcare Holdings Berhad
6. Datuk Bill Tan, Managing Director of Corporate Finance, M&A Securities Sdn Bhd
7. Dr. Lai Ngan Chee, Executive Director, DC Healthcare Holdings Berhad
8. Ms. Yap Ee Ling, Independent Non-Executive Director, DC Healthcare Holdings Berhad
9. Mr. Danny Wong, Deputy Head of Corporate Finance, M&A Securities Sdn Bhd [L-R]
( https://photos.acnnewswire.com/tr:n-650/2023627.DCHealthcare2.jpg )